QCM
BBNX

Quantinno Capital Management’s Beta Bionics BBNX Stock Holding History

Quantinno Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Sell
24,064
-43,815
-65% -$521K ﹤0.01% 3117
2026
Q1 		$680K Buy
67,879
+35,996
+113% +$532K ﹤0.01% 2482
2025
Q4 		$971K Buy
31,883
+5,273
+20% +$141K ﹤0.01% 1818
2025
Q3 		$529K Buy
26,610
+6,840
+35% +$120K ﹤0.01% 1970
2025
Q2 		$288K Buy
+19,770
New +$280K ﹤0.01% 2054

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Quantinno Capital Management's BBNX Position: Q2 2026 in Review

Quantinno Capital Management reduced its Beta Bionics (BBNX) stake by 65% in Q2 2026, selling an estimated $521K and leaving 24,064 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

Quantinno Capital Management first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $971K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Quantinno Capital Management held 24,064 shares of Beta Bionics worth $377K as of Q2 2026.
  • Quantinno Capital Management sold 43,815 Beta Bionics shares in Q2 2026, an estimated $521K.
  • Beta Bionics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3117 holding.
  • Quantinno Capital Management first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • Quantinno Capital Management's Beta Bionics position peaked at $971K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.